Business
GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies
PALO ALTO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- GEn1E Lifesciences, a clinical-stage Phase 2 company, and a leading innovator in precision therapies for inflammatory and rare diseases, with a strong partnership with the University of Maryland, B
By: manilatimes
- Oct 14 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS